Merger Creates one of the Largest Population Health Management Platforms in the U.S.

GLENDALE, Calif., Dec. 11, 2017 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, and Network Medical Management, Inc. ("NMM"), one of the largest Management Services Organizations ("MSOs") in the United States, today announced the successful completion of their merger.  The newly combined company, which will continue as Apollo Medical Holdings, brings together two leading, complementary healthcare organizations to form one of the nation's largest population health management companies, and will coordinate the care and provide medical management for over 700,000 patients in Californiathrough a network of over 4000 contracted physicians and over 400 employees.

Additionally, ApolloMed's shares of common stock were approved for listing on The Nasdaq Capital Market ("NASDAQ").  The Company's common stock began trading on NASDAQ on December 8, 2017 under the ticker symbol "AMEH".  ApolloMed's management team will ring the closing bell at the NASDAQ MarketSite in Times Square in New York City today at 4pm Eastern Time.

On an unaudited pro forma basis, the newly combined company would have had revenues of $125.7 million for the three months ended June 30, 2017 and would have had positive operating and net income.

The Company's data-enabled clinical platform provides care for patients whether they are in the hospital, in a skilled nursing facility or at home, and also includes end-of-life care through its hospice/palliative care program and high-risk medical management program for patients with multiple chronic illnesses.  Its MSO platform will be able to provide the full suite of solutions for physicians, independent physician associations ("IPAs"), medical groups, managed care organizations, hospitals and accountable care organizations ("ACOs"), including claims processing/adjudication, credentialing, contracting, and data collection, analysis and reporting.  ApolloMed's proprietary cloud and mobile-based population health management platform, Apollo Care Connect, includes evidence-based digital care plans for patients with chronic illnesses, a personal health assistant that allows patients to view their health data and to interact real-time with their physician and care managers, an inpatient dashboard, and a care management module, and has the ability to extract clinical and claims data from multiple EHR and claims systems.

ApolloMed will be led by Warren Hosseinion, M.D. and Thomas Lam, M.D. as Co-Chief Executive Officers, Kenneth Sim, M.D. as Executive Chairman, Gary Augusta as President, Mihir Shah as Chief Financial Officer, and Hing Ang as Chief Operating Officer.  Adrian Vazquez, M.D. and Albert Young, M.D. will be Co-Chief Medical Officers.

The Board of Directors will consist of nine directors: five appointees (including three independent directors) from NMM and four appointees (including two independent directors) from ApolloMed.  The NMM appointees are Thomas Lam, M.D., Kenneth Sim, M.D., Li Yu, Mitchell Kitayama and Michael Eng.  The ApolloMed appointees are Warren Hosseinion, M.D., Gary Augusta, Dave Schmidt and Mark Fawcett.

"We are very pleased to announce the completion of our merger with Network Medical Management to create one of the leading population health management companies in the nation," stated Warren Hosseinion, M.D., Co-Chief Executive Officer of Apollo Medical Holdings.  "Our technology-enabled platform allows us to provide a comprehensive suite of solutions for physicians, hospitals, managed care organizations and accountable care organizations.  We see tremendous growth opportunities ahead."

"Our two organizations complement each other and we believe this will allow us to advance our integrated care delivery model," stated Thomas Lam, M.D., Co-Chief Executive Officer of Apollo Medical Holdings.  "We believe the combination of the resources of our two organizations is unique, and we are really excited about the future."

"Both of our organizations have a history of providing high-quality, coordinated care that is cost effective and focused on outcomes," stated Kenneth Sim, M.D., Executive Chairman of Apollo Medical Holdings. "Through this combination, we aim to become the industry leader in the transition of U.S. healthcare to value-based reimbursements."

"We would like to thank our existing shareholders and welcome our new shareholders," stated Gary Augusta, President of Apollo Medical Holdings.  "This merger, along with our listing on NASDAQ, are important milestones as we continue to build shareholder value."

Advisors
BofA Merrill Lynch acted as exclusive financial advisor to ApolloMed.  McDermott Will & Emery served as legal counsel to ApolloMed.   Vantage Point Advisors acted as exclusive financial advisor to Network Medical Management and the Law Offices of Tin Kin Lee served as NMM's legal counsel.

About Apollo Medical Holdings, Inc. (ApolloMed)
ApolloMed is a leading physician-centric integrated population health management company working to provide coordinated, outcomes-based high-quality medical care for patients, particularly senior patients and patients with multiple chronic conditions, in a cost-effective manner.  Led by a management team with over two decades of experience,  ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated health management and healthcare delivery platform that includes: Network Medical Management (MSO),  Apollo Medical Management (MSO), ApolloMed Hospitalists, APA ACO (Next Generation ACO), ApolloMed ACO (MSSP Accountable Care Organization), Allied Physicians of California (IPA),  Maverick Medical Group (IPA), Apollo Care Connect (Digital Population Health Management Platform) and ApolloMed Palliative Services (Hospice/Palliative Care and Home Health Care). ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care.  For more information, please visit www.apollomed.net

Contact Information

Oded Levy, Partner                                                                      
oded@blueoxhcp.com 
(917) 545-4046

 


Blue Ox Healthcare Partners Exits Delphi Behavioral Health Group

New York, October 11, 2017 -- Blue Ox Healthcare Partners, LLC, a specialized private equity firm investing growth capital in the healthcare industry, has exited Delphi Behavioral Health Group, LLC, a portfolio company investment, through a sale to private investment firm The Halifax Group. Delphi is a growing leader in providing chemical dependence and addiction treatment services with 11 boutiquestyle recovery centers in FL, CA and MD.

The chemical dependence and addiction treatment industry is estimated to be $35 billion according to the National Survey on Drug Use and Health, but is highly fragmented and difficult to navigate. In working with the predecessor companies that eventually formed Delphi as it stands today, Blue Ox was early in recognizing the potential synergies and attractiveness of combining a growing boutique treatment program with an advanced technology engagement platform.

Blue Ox, led by Managing Partner Oded Levy, with its collaborative, hands-on approach in working with the management teams resulted in a company proven to be highly scalable and profitable. The combined platform of Delphi provides differentiated high-touch, evidenced-based therapy and aftercare services that is positioned to continue to succeed and grow in today’s marketplace.

"Oded Levy and the Blue Ox team were great partners and provided valuable financial insight and expertise during the initial phases of our growth,” said Delphi CEO, Dominic Sirianni. “They brought a depth and breadth of healthcare knowledge to the company that helped us navigate the first three years of growth."

Blue Ox played a pivotal role in the formation of Delphi and guided it to value over a three-year period. The original investment began in Q3 2014 in the creation of Delphi’s predecessor company, DHG, with Blue Ox contributing capital and other founders led by Ryan Collison and current Delphi CEO Dominic Sirianni contributing assets in the form of two treatment centers. In March 2016, Blue Ox shepherded a merger with three private companies and a $26 million debt recapitalization by KeyBanc, to form the present Delphi. Blue Ox held an active board seat throughout its involvement and an executive position internally supporting Delphi’s financial progress during the inception.

“The Delphi team is in an outstanding position for growth,” said Oded Levy, Managing Partner of Blue Ox. “Building innovative businesses is what we love to do and Delphi has been one of our most successful investments. We are delighted to have been involved from the ground up and played a part in the success of Delphi as they ready for their next phase.”

Blue Ox Healthcare Partners, LLC is a specialized private equity firm investing in middle market growthstage companies in the healthcare sector, with an emphasis on healthcare services, HCIT, and medical and life sciences technologies. The Blue Ox team has extensive expertise in building and exiting profitable, sustainable healthcare businesses, and Blue Ox’s platform provides its investors with the best features of direct investing and traditional private equity management. For more information, please visit www.blueoxhcp.com or contact info@blueoxhcp.com.

Media inquiries:

Hyacinth Chu
Citigate Dewe Rogerson
E: hyacinth.chu@citigatedr.com
D: (917) 362-8798
http://www.citigatedewerogerson.com/

Contact Information

Oded Levy, Partner                                                                      
oded@blueoxhcp.com 
(917) 545-4046


 

PRNewseire: ApolloMed And Network Medical Management Announce Transformational Merger

Contact Information

Oded Levy, Partner                                                                      
oded@blueoxhcp.com 
(917) 545-4046



Blue Ox Healthcare Partners, LLC is pleased to announce that on March 2, 2016, Delphi Behavioral Health Group, LLC, a portfolio investment of Blue Ox, closed on $26 million of Senior Secured Credit Facilities from KeyBanc Capital Markets.  The facilities consisted of a $5 million Revolving Credit Facility and a $21 million Term Loan.  The facilities will support Delphi’s acquisition and shareholder buyout strategy.

Delphi Behavioral Health Group, LLC is a chemical dependence and addiction treatment company offering treatment services throughout all stages of a patients’ addiction.  The Company utilizes cognitive and behavioral therapies customized to each patient offering trauma resolution rather than treatment through medication.  Delphi leverages its evidence based therapy program with tailored aftercare offering services such as assessment, detoxification, counseling, education, didactic lectures and group therapy.  Delphi is headquartered in Ft. Lauderdale, Florida with locations across California, Maryland and Florida.

Blue Ox Healthcare Partners, LLC is a private investment firm focused on identifying and partnering with middle market companies who are participating and driving structural changes in healthcare.  We partner with these companies to help them create and grow more sustainable and valuable businesses for the future.  

Contact Information

Oded Levy, Partner                                                                      
oded@blueoxhcp.com 
(917) 545-4046


Blue Ox Healthcare Partners, LLC is pleased to announce that on January 12, 2016, the population health management technology and operating platform of Healarium, Inc., a portfolio investment of Blue Ox, was acquired by  Apollo Care Connect, a wholly-owned subsidiary of Apollo Medical Holdings, Inc. (“ApolloMed” or the “Company”).  The acquisition expands ApolloMeds medical management and care coordination capabilities and positions the company for further market expansion. Blue Ox received equity shares of ApolloMed as part of the consideration in the transaction and is continuing as an investor in the Company.

Healarium, founded in 2009, provides a cloud and mobile-based population health management platform, with an emphasis on chronic care management and total patient engagement. Among its distinctive components are a Care Management Dashboard which allows care managers to quickly focus on high-risk patients, Digital Care Plans which use evidence-based protocols, and a Personal Health Assistant, accessible via mobile or web, that allows patients to view their health data, care plans, receive alerts and to track goal progress. With one click, physicians and care managers can prescribe patients a clinically appropriate and comprehensive treatment plan. This care plan is personalized and includes daily regimens which leverage ApolloMeds expertise in clinical care, care coordination and medical risk management. Healariums platform has reduced expenditures in patients with chronic conditions and also reduced hospital readmissions and emergency room visits. Additionally, the platform supports the requirements to satisfy the Centers for Medicare and Medicaid Services ("CMS") Chronic Care Management ("CCM") reimbursements for those Medicare enrollees with two or more chronic conditions. Healarium has the capability to aggregate data from multiple sources, including hospital and physician electronic health records. Healarium will continue to support Apollo Care Connects growth. “We believe that engaging patients in their own care is an important part of the changing landscape of healthcare," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc. "Healariums technology platform will further enable us to meet the new challenges in the evolving world of value-based reimbursements.” "Combining ApolloMeds clinical expertise and performance-based financial models with a robust chronic care management software platform is a powerful solution to todays healthcare needs," stated Gary Augusta, Executive Chairman of Apollo Medical Holdings, Inc. "We look forward to working with our existing and future hospital, health plan and medical group partners who are looking to transition to a value-based care model."

Apollo Medical Holdings, Inc. (ApolloMed), headquartered in Glendale, California, is a leading integrated population health management company committed to providing exceptional multi-disciplinary care in the communities it serves. ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of six affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group, AKM Medical Group, ApolloMed Care Clinics and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. 

Blue Ox Healthcare Partners, LLC is a private investment firm focused on identifying and partnering with middle market companies who are participating and driving structural changes in healthcare.  We partner with these companies to help them create and grow more sustainable and valuable businesses for the future.

Contact Information

Oded Levy, Partner                                                                      
oded@blueoxhcp.com 
(917) 545-4046